June 6, 2026 Inflammation as a Hidden Driver of Cardiovascular Risk: AI Scans and Immunotherapy Breakthroughs
June 4, 2026 Phase 1 Trial of AAV8-Mediated LDL Receptor Gene Therapy for Familial Hypercholesterolemia
